TOP TEN perturbations for 1553657_at (Homo sapiens)

Organism: Homo sapiens
Gene: 1553657_at
Selected probe(set): 238864_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 1553657_at (238864_at) across 6672 perturbations tested by GENEVESTIGATOR:

ovarian tumor study 15 / normal ovarian surface epithelial cell sample

Relative Expression (log2-ratio):2.7545986
Number of Samples:4 / 4
Experimental ovarian tumor study 15
Human pooled cancer samples from the ovary of patients with low-malignant (borderline) serous carcinoma of the ovary.
Control normal ovarian surface epithelial cell sample
Human epithelial cell samples from histopathological normal and non-cancerous ovary tissue from donors with non-cancerous, benign gynecological diseases.

ovarian tumor study 11 (low grade) / normal ovarian surface epithelial cell sample

Relative Expression (log2-ratio):2.409562
Number of Samples:11 / 6
Experimental ovarian tumor study 11 (low grade)
Human microdissected tumor cells from the ovary of patients with low grade serous carcinoma.
Control normal ovarian surface epithelial cell sample
Human microdissected ovarian surface epithelial cell sample from the ovary of healthy individuals.

ovarian tumor study 14 / ovarian tumor study 15

Relative Expression (log2-ratio):-2.2806282
Number of Samples:4 / 4
Experimental ovarian tumor study 14
Human pooled cancer samples from the ovary of patients with moderate and poorly differentiated serous carcinoma of the ovary.
Control ovarian tumor study 15
Human pooled cancer samples from the ovary of patients with low-malignant (borderline) serous carcinoma of the ovary.

ovarian tumor study 27 (papillary serous cystadenocarcinoma; metastase) / ovarian tumor study 27 (papillary serous cystadenocarcinoma; bmp; primary)

Relative Expression (log2-ratio):-2.179843
Number of Samples:53 / 18
Experimental ovarian tumor study 27 (papillary serous cystadenocarcinoma; metastase)
Metastatic tumor tissue samples obtained from different anatomical sites (colon, omentum, peritoneum and unstated sites) of female patients with primary papillary serous cystadenocarcinoma of the ovary.
Control ovarian tumor study 27 (papillary serous cystadenocarcinoma; bmp; primary)
Primary tumor tissue samples obtained from the ovary of female patients with papillary serous cystadenocarcinoma with borderline malignant potential (bmp).

ovarian tumor study 26 (serous carcinoma; metastase; peritoneum) / ovarian tumor study 26 (serous carcinoma; borderline; primary)

Relative Expression (log2-ratio):-2.1792507
Number of Samples:15 / 30
Experimental ovarian tumor study 26 (serous carcinoma; metastase; peritoneum)
Metastatic tumor tissue sample obtained from the peritoneum of female patients with primary serous cystadenocarcinoma of the ovary.
Control ovarian tumor study 26 (serous carcinoma; borderline; primary)
Ovarian tissue samples from female patients with primary serous cystadenoma with low malignant potential (borderline).

ovarian tumor study 11 (high grade) / ovarian tumor study 11 (low grade)

Relative Expression (log2-ratio):-2.1634579
Number of Samples:22 / 11
Experimental ovarian tumor study 11 (high grade)
Human microdissected tumor cells from the ovary of patients with high grade serous carcinoma.
Control ovarian tumor study 11 (low grade)
Human microdissected tumor cells from the ovary of patients with low grade serous carcinoma.

brain tumor study 1 (medulloblastoma) / brain tumor study 1 (ependymoma)

Relative Expression (log2-ratio):-1.9803228
Number of Samples:22 / 46
Experimental brain tumor study 1 (medulloblastoma)
Primary tumor tissue sample from the brain of patients with medulloblastoma.
Control brain tumor study 1 (ependymoma)
Primary tumor tissue sample from the brain of patients with ependymoma.

ovarian tumor study 11 (borderline) / normal ovarian surface epithelial cell sample

Relative Expression (log2-ratio):1.9729042
Number of Samples:8 / 6
Experimental ovarian tumor study 11 (borderline)
Human microdissected tumor cells from the ovary of patients with low-malignant (borderline) tumors of the ovary.
Control normal ovarian surface epithelial cell sample
Human microdissected ovarian surface epithelial cell sample from the ovary of healthy individuals.

ovarian tumor study 26 (serous carcinoma; malignant; primary) / ovarian tumor study 26 (serous carcinoma; borderline; primary)

Relative Expression (log2-ratio):-1.9656963
Number of Samples:44 / 30
Experimental ovarian tumor study 26 (serous carcinoma; malignant; primary)
Ovarian tissue samples from female patients with primary serous cystadenocarcinoma.
Control ovarian tumor study 26 (serous carcinoma; borderline; primary)
Ovarian tissue samples from female patients with primary serous cystadenoma with low malignant potential (borderline).

ovarian tumor study 27 (papillary serous cystadenocarcinoma; primary) / ovarian tumor study 27 (papillary serous cystadenocarcinoma; bmp; primary)

Relative Expression (log2-ratio):-1.9114971
Number of Samples:153 / 18
Experimental ovarian tumor study 27 (papillary serous cystadenocarcinoma; primary)
Primary tumor tissue samples obtained from the ovary of female patients with papillary serous cystadenocarcinoma.
Control ovarian tumor study 27 (papillary serous cystadenocarcinoma; bmp; primary)
Primary tumor tissue samples obtained from the ovary of female patients with papillary serous cystadenocarcinoma with borderline malignant potential (bmp).